Black Bird Biotech, Inc. (BBBT)

Market Cap	3.73K
Revenue (ttm)	36.32K
Net Income (ttm)	-836.14K
Shares Out	3.73B
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000,000
Average Volume	55,250
Open	0.0000
Previous Close	n/a
Day's Range	0.0000 - 0.0000
52-Week Range	0.0000 - 0.0002
Beta	2.86
RSI	26.84
Earnings Date	May 21, 2025

About Black Bird Biotech

Black Bird Biotech Inc. provides various biotech products. It manufactures and distributes MiteXstream, a plant-based biopesticide for the eradication of spider mites. The company also manufactures and sells CBD Oils, gummies and pet treats, CBD-infused personal care products, and hand sanitizer under the Grizzly Creek Naturals brand name. In addition, it grows industrial hemp under the Montana Hemp pilot program. The company was formerly known as Digital Development Partners, Inc. and changed its name to Black Bird Biotech, Inc. in June 2021. ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Nelson Grist
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: BBBT

Financial Performance

In 2022, Black Bird Biotech's revenue was $82,563, a decrease of -20.96% compared to the previous year's $104,458. Losses were -$1.66 million, -8.42% less than in 2021.